News
Governor Hochul Announces Third Round of Biodefense Commercialization Fund Awards to Combat Infectious Disease Threats
Overview
Governor Kathy Hochul today announced the third round of awardees for the $40 Million New York State Biodefense Commercialization Fund. The program was created to accelerate the development and commercialization of life science innovations that address serious infectious disease threats, including COVID-19 and its variants, while also creating jobs and encouraging continued growth across New York’s expanding life science industry. Upon approval by the Empire State Development Board of Directors, four grants will be awarded for this round, representing a combined commitment of more than $3 million.
The Big Picture
To Date, More Than $25 Million Awarded to 11 Start-Ups and 16 Academic Institutions
$3 Million for Round Three Awardees Focusing on Rapid and Point-of-Care Diagnostics and Surveillance Tools
Keeping New York State at the Forefront of Infectious Disease Discovery and Development
